Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
- Previous Close
2.9000 - Open
3.0000 - Bid 2.8450 x --
- Ask 2.8800 x --
- Day's Range
2.8100 - 3.0000 - 52 Week Range
2.4300 - 23.4950 - Volume
69,733 - Avg. Volume
92,564 - Market Cap (intraday)
73.92M - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
-- - EPS (TTM)
-4.3000 - Earnings Date May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.00
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
www.clinicallaser.seRecent News: CLS-B.ST
View MorePerformance Overview: CLS-B.ST
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLS-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLS-B.ST
View MoreValuation Measures
Market Cap
73.92M
Enterprise Value
51.64M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.11
Price/Book (mrq)
1.08
Enterprise Value/Revenue
2.78
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-253.54%
Return on Assets (ttm)
-50.24%
Return on Equity (ttm)
-87.64%
Revenue (ttm)
18.78M
Net Income Avi to Common (ttm)
-47.62M
Diluted EPS (ttm)
-4.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
22.51M
Total Debt/Equity (mrq)
0.34%
Levered Free Cash Flow (ttm)
-44.49M